Literature DB >> 17061288

Etiology of strokes in children with sickle cell anemia.

Michael R Debaun1, Colin P Derdeyn, Robert C McKinstry.   

Abstract

The most devastating complication of sickle cell anemia is cerebral infarction, affecting approximately 30% of all individuals with sickle cell anemia. Despite being one of the most common causes of stroke in infants and children, the mechanism of cerebral infarction in this population has not been extensively studied and is poorly understood. Multiple, synergistic factors are important in the pathogenesis of stroke including the hemodynamic effects of cerebral arterial occlusive disease, viscosity, chronic and acute anemia and acute medical events. This review focuses on the relationship between these factors in order to provide a foundation for further study of the etiology of strokes in this high-risk population. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061288     DOI: 10.1002/mrdd.20118

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  20 in total

1.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2016-10

Review 2.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

Review 3.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2017-01-17

4.  Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting.

Authors:  Meher R Juttukonda; Manus J Donahue; Spencer L Waddle; Larry T Davis; Chelsea A Lee; Niral J Patel; Sumit Pruthi; Adetola A Kassim; Lori C Jordan
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-11       Impact factor: 6.200

5.  Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia.

Authors:  Meher R Juttukonda; Manus J Donahue; Larry T Davis; Melissa C Gindville; Chelsea A Lee; Niral J Patel; Adetola A Kassim; Sumit Pruthi; Jeroen Hendrikse; Lori C Jordan
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-20       Impact factor: 6.200

6.  Differential cerebral hemometabolic responses to blood transfusions in adults and children with sickle cell anemia.

Authors:  Meher R Juttukonda; Chelsea A Lee; Niral J Patel; Larry T Davis; Spencer L Waddle; Melissa C Gindville; Sumit Pruthi; Adetola A Kassim; Michael R DeBaun; Manus J Donahue; Lori C Jordan
Journal:  J Magn Reson Imaging       Date:  2018-10-15       Impact factor: 4.813

Review 7.  Prospects for primary stroke prevention in children with sickle cell anaemia.

Authors:  Lori C Jordan; James F Casella; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

8.  Cerebral hemodynamics and pseudo-continuous arterial spin labeling considerations in adults with sickle cell anemia.

Authors:  Meher R Juttukonda; Lori C Jordan; Melissa C Gindville; Larry T Davis; Jennifer M Watchmaker; Sumit Pruthi; Manus J Donahue
Journal:  NMR Biomed       Date:  2017-01-04       Impact factor: 4.044

9.  Acute silent cerebral infarction in children with sickle cell anemia.

Authors:  Michael M Dowling; Charles T Quinn; Zora R Rogers; George R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

10.  Evaluation of SWI in children with sickle cell disease.

Authors:  A M Winchell; B A Taylor; R Song; R B Loeffler; P Grundlehner; J S Hankins; W C Wang; R J Ogg; C M Hillenbrand; K J Helton
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-21       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.